The North America Biopsy Devices Market should witness market growth of 6.4% CAGR during the forecast period (2022-2028).
CT scans and MRIs are used to spot irregular tissue or masses; however, they can’t tell the variance between cancer and non-cancer cells. So, the biopsy is performed to closely inspect collected cells to make a precise cancer diagnosis. Needle biopsy is mainly used for breast lumps and enlarged lymph nodes. When needle biopsy is used with CT scans and MRIs, it can collect cells from a part that is not felt over the skin.
In endoscopy, doctors use a thin endoscope (flexible tube) with a torch to see the inside structure of the body. Special tools are put inside the tube to study the sample tissue to take out the tissue from the infected area. Skin biopsy removes cells from the surface of one’s body. It is used for analysing skin conditions such as melanoma and other cancers.
The kind of skin biopsy one may go through depends on the form of cancer that the doctors and the number of wary cells assume. Bone marrow biopsy is constructed based on blood test outcomes or if the doctors think the tumour is affecting the bone marrow.
According to CDC, in 2019, 1, 752, 735 new cancer cases were found, while 599, 589 people died because of cancer in the United States. 439 new cases of cancer were discovered, while 146 people were found dead from cancer of every 100, 000 people. Medical equipment sector of Canada provide opportunities to the investors of United States in the Canadian market. Total imports of medical gadgets satisfies about 70% of local demand.
The US market dominated the North America Biopsy Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $850.3 million by 2028. The Canada market is poised to grow at a CAGR of 8.8% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 7.9% during (2022-2028).
Based on Product, the market is segmented into Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps and Others. Based on Needle-based Biopsy Guns Type, the market is segmented into Vacuum-assisted Biopsy (VAB) Devices, Fine Needle Aspiration Biopsy (FNAB) Devices and Core Needle Biopsy (CNB) Devices. Based on Biopsy Guidance Systems Type, the market is segmented into Manual and Robotic. Based on Biopsy Needles Type, the market is segmented into Disposable and Reusable. Based on End-user, the market is segmented into Hospitals, Diagnostic & Imaging Center and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Hologic, Inc., Fujifilm Holdings Corporation, B. Braun Melsungen AG, Danaher Corporation, ConMed Corporation, Becton, Dickinson and Company, Cardinal Health, Inc., Argon Medical Devices, Inc., and Cook Medical, Inc.
CT scans and MRIs are used to spot irregular tissue or masses; however, they can’t tell the variance between cancer and non-cancer cells. So, the biopsy is performed to closely inspect collected cells to make a precise cancer diagnosis. Needle biopsy is mainly used for breast lumps and enlarged lymph nodes. When needle biopsy is used with CT scans and MRIs, it can collect cells from a part that is not felt over the skin.
In endoscopy, doctors use a thin endoscope (flexible tube) with a torch to see the inside structure of the body. Special tools are put inside the tube to study the sample tissue to take out the tissue from the infected area. Skin biopsy removes cells from the surface of one’s body. It is used for analysing skin conditions such as melanoma and other cancers.
The kind of skin biopsy one may go through depends on the form of cancer that the doctors and the number of wary cells assume. Bone marrow biopsy is constructed based on blood test outcomes or if the doctors think the tumour is affecting the bone marrow.
According to CDC, in 2019, 1, 752, 735 new cancer cases were found, while 599, 589 people died because of cancer in the United States. 439 new cases of cancer were discovered, while 146 people were found dead from cancer of every 100, 000 people. Medical equipment sector of Canada provide opportunities to the investors of United States in the Canadian market. Total imports of medical gadgets satisfies about 70% of local demand.
The US market dominated the North America Biopsy Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $850.3 million by 2028. The Canada market is poised to grow at a CAGR of 8.8% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 7.9% during (2022-2028).
Based on Product, the market is segmented into Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps and Others. Based on Needle-based Biopsy Guns Type, the market is segmented into Vacuum-assisted Biopsy (VAB) Devices, Fine Needle Aspiration Biopsy (FNAB) Devices and Core Needle Biopsy (CNB) Devices. Based on Biopsy Guidance Systems Type, the market is segmented into Manual and Robotic. Based on Biopsy Needles Type, the market is segmented into Disposable and Reusable. Based on End-user, the market is segmented into Hospitals, Diagnostic & Imaging Center and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Hologic, Inc., Fujifilm Holdings Corporation, B. Braun Melsungen AG, Danaher Corporation, ConMed Corporation, Becton, Dickinson and Company, Cardinal Health, Inc., Argon Medical Devices, Inc., and Cook Medical, Inc.
Scope of the Study
By Product
- Needle-based Biopsy Guns
- Vacuum-assisted Biopsy (VAB) Devices
- Fine Needle Aspiration Biopsy (FNAB) Devices
- Core Needle Biopsy (CNB) Devices
- Biopsy Guidance Systems
- Manual
- Robotic
- Biopsy Needles
- Disposable
- Reusable
- Biopsy Forceps
- Others
By End-user
- Hospitals
- Diagnostic & Imaging Center
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Hologic, Inc.
- Fujifilm Holdings Corporation
- B.Braun Melsungen AG
- Danaher Corporation
- ConMed Corporation
- Becton, Dickinson and Company
- Cardinal Health, Inc.
- Argon Medical Devices, Inc.
- Cook Medical, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Biopsy Devices Market, by Product
1.4.2 North America Biopsy Devices Market, by End User
1.4.3 North America Biopsy Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition &Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Biopsy Devices Market by Product
3.1 North America Needle-based Biopsy Guns Market by Country
3.2 North America Biopsy Devices Market by Needle-based Biopsy Guns Type
3.2.1 North America Vacuum-assisted Biopsy (VAB) Devices Market by Country
3.2.2 North America Fine Needle Aspiration Biopsy (FNAB) Devices Market by Country
3.2.3 North America Core Needle Biopsy (CNB) Devices Market by Country
3.3 North America Biopsy Guidance Systems Market by Country
3.4 North America Biopsy Devices Market by Biopsy Guidance Systems Type
3.4.1 North America Manual Market by Country
3.4.2 North America Robotic Market by Country
3.5 North America Biopsy Needles Market by Country
3.6 North America Biopsy Devices Market by Biopsy Needles Type
3.6.1 North America Disposable Market by Country
3.6.2 North America Reusable Market by Country
3.7 North America Biopsy Forceps Market by Country
3.8 North America Others Market by Country
Chapter 4. North America Biopsy Devices Market by End User
4.1 North America Hospitals Market by Country
4.2 North America Diagnostic & Imaging Center Market by Country
4.3 North America Others Market by Country
Chapter 5. North America Biopsy Devices Market by Country
5.1 US Biopsy Devices Market
5.1.1 US Biopsy Devices Market by Product
5.1.1.1 US Biopsy Devices Market by Needle-based Biopsy Guns Type
5.1.1.2 US Biopsy Devices Market by Biopsy Guidance Systems Type
5.1.1.3 US Biopsy Devices Market by Biopsy Needles Type
5.1.2 US Biopsy Devices Market by End User
5.2 Canada Biopsy Devices Market
5.2.1 Canada Biopsy Devices Market by Product
5.2.1.1 Canada Biopsy Devices Market by Needle-based Biopsy Guns Type
5.2.1.2 Canada Biopsy Devices Market by Biopsy Guidance Systems Type
5.2.1.3 Canada Biopsy Devices Market by Biopsy Needles Type
5.2.2 Canada Biopsy Devices Market by End User
5.3 Mexico Biopsy Devices Market
5.3.1 Mexico Biopsy Devices Market by Product
5.3.1.1 Mexico Biopsy Devices Market by Needle-based Biopsy Guns Type
5.3.1.2 Mexico Biopsy Devices Market by Biopsy Guidance Systems Type
5.3.1.3 Mexico Biopsy Devices Market by Biopsy Needles Type
5.3.2 Mexico Biopsy Devices Market by End User
5.4 Rest of North America Biopsy Devices Market
5.4.1 Rest of North America Biopsy Devices Market by Product
5.4.1.1 Rest of North America Biopsy Devices Market by Needle-based Biopsy Guns Type
5.4.1.2 Rest of North America Biopsy Devices Market by Biopsy Guidance Systems Type
5.4.1.3 Rest of North America Biopsy Devices Market by Biopsy Needles Type
5.4.2 Rest of North America Biopsy Devices Market by End User
Chapter 6. Company Profiles
6.1 Medtronic PLC
6.1.1 Company overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 SWOT Analysis
6.2 Hologic, Inc
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Acquisition and Mergers:
6.3 Fujifilm Holdings Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expenses
6.4 B. Braun Melsungen AG
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.5 Danaher Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 ConMed Corporation
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.7 Becton, Dickinson and Company
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.8 Cardinal Health, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.9 Argon Medical Devices, Inc.
6.9.1 Company Overview
6.10. Cook Medical, Inc. (Cook Group)
6.10.1 Company Overview
Companies Mentioned
- Medtronic PLC
- Hologic, Inc.
- Fujifilm Holdings Corporation
- B. Braun Melsungen AG
- Danaher Corporation
- ConMed Corporation
- Becton, Dickinson and Company
- Cardinal Health, Inc.
- Argon Medical Devices, Inc.
- Cook Medical, Inc.
Methodology
LOADING...
